Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients

Sialidosis is a lysosomal storage disease caused by the deficiency of alpha-N-acetyl neuraminidase-1 (NEU1). Sialidosis is classified into two main clinical variants: Type I, the milder form of the disease, and Type II, which can in turn be subdivided into three forms: congenital, infantile and juvenile. We report herein the clinical, biochemical and molecular characterisation of two patients with Type II sialidosis exhibiting the congenital (P1) and infantile forms (P2). We also review clinical data on the rare Type II forms of sialidosis in the hope of improving understanding of the disorder and facilitating its diagnosis. The genetic characterization of the two patients showed one known [c. 679G > A (p.G227R)] NEU1 missense mutation (detected in P2), and the new c.807 + 1G > A splicing defect (detected in P1), a genetic lesion that is extremely rare in this disease. Interestingly, P2 presented an extremely elevated level of chitotriosidase in plasma. This is the first pathological detection of chitotriosidase in sialidosis patients.

[1]  O. Linderkamp,et al.  Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. , 1999, American journal of perinatology.

[2]  Smuckler Ea,et al.  A severe infantile mucolipidosis. Clinical, biochemical, and pathologic features. , 1983 .

[3]  A. Pshezhetsky,et al.  Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes , 2002, Journal of Human Genetics.

[4]  G. Buheitel,et al.  Colour Doppler imaging of intracranial vasculopathy in severe infantile sialidosis , 2005, Pediatric Radiology.

[5]  R. W. Logan,et al.  Infantile type 2 sialidosis in a Pakistani family — a clinical and biochemical study , 1984, Journal of Inherited Metabolic Disease.

[6]  H. Galjaard,et al.  Elevated plasma chitotriosidase activity in various lysosomal storage disorders , 1995, Journal of Inherited Metabolic Disease.

[7]  E. Cutz,et al.  Congenital ascites as a presenting sign of lysosomal storage disease. , 1984, The Journal of pediatrics.

[8]  F. Graham,et al.  Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus‐mediated expression , 2004, Human mutation.

[9]  R. Winter,et al.  Sialidosis Type II (Acid Neuraminidase Deficiency): Clinical and Biochemical Features of a Further Case , 1980 .

[10]  Y. Bertrand,et al.  Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean? , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  K. Lukong,et al.  Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation , 2001, European Journal of Pediatrics.

[12]  G. González,et al.  Manejo anestésico de un paciente con sialidosis , 2006 .

[13]  K. Lukong,et al.  Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. , 2000, Human molecular genetics.

[14]  R. Penzel,et al.  Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient , 2002, FEBS letters.

[15]  A. Pshezhetsky,et al.  Clinical variability of type II sialidosis by C808T mutation , 2003, American journal of medical genetics. Part A.

[16]  J. R. Moore,et al.  Neuraminidase deficiency: case report and review of the phenotype. , 1987, Journal of medical genetics.

[17]  M. Natowicz,et al.  Plasma chitotriosidase in lysosomal storage diseases. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[18]  David J. Loren,et al.  Sialidosis Presenting as Severe Nonimmune Fetal Hydrops is Associated with Two Novel Mutations in Lysosomal α-Neuraminidase , 2005, Journal of Perinatology.

[19]  R. Winter,et al.  Sialidosis type 2 (acid neuraminidase deficiency): clinical and biochemical features of a further case , 1980, Clinical genetics.

[20]  R. Penzel,et al.  Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient , 2001, FEBS letters.

[21]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[22]  W. Arts,et al.  Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. , 2000, Human molecular genetics.

[23]  E. Smuckler,et al.  A severe infantile mucolipidosis. Clinical, biochemical, and pathologic features. , 1983, Archives of pathology & laboratory medicine.

[24]  I. Akaboshi,et al.  The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: Possible linkage between HLA and the neuraminidase deficiency gene , 1985, Human Genetics.

[25]  M. Beck,et al.  Neuraminidase deficiency presenting as non-immune hydrops fetalis , 1984, European Journal of Pediatrics.

[26]  K. Inui,et al.  Pathological study on a severe sialidosis (α-neuraminidase deficiency) , 2004, Acta Neuropathologica.

[27]  L. Bartoshesky,et al.  Mucolipidosis I (acid neuraminidase deficiency). Three cases and delineation of the variability of the phenotype. , 1981, American journal of diseases of children.

[28]  H. Michelakakis,et al.  The expanding spectrum of disorders with elevated plasma chitotriosidase activity:An update , 2004, Journal of Inherited Metabolic Disease.